Can HPV Cause Mouth Cancer?

Human Papillomavirus (HPV) is a common sexually transmitted infection that can affect various parts of the body, including the mouth and throat. While HPV is most associated with cervical cancer, there is growing awareness of its potential link to oral cancers, particularly those affecting the mouth and throat.  

There exist over 100 variants of HPV, with approximately 40 capable of transmission to the genital, oral, or throat areas via direct sexual contact. Scientists suspect that high-risk strains of HPV contribute to a rise in oropharyngeal squamous cell carcinoma (SCC), the second most prevalent form of skin cancer. These HPV strains are linked to cervical and anal cancers. 

In this blog, we will delve into the connection between HPV mouth cancer, exploring the risk factors, symptoms, diagnosis, treatment options, and preventive measures. 

Understanding HPV and Its Types

Human Papillomavirus encompasses a group of viruses that can infect both skin and mucous membranes. This infection spreads through sexual contact, including oral, vaginal, and anal sex. While many HPV infections resolve on their own without causing symptoms or health issues, some strains, including HPV16, are linked to various cancers like cervical, anal, penile, and oropharyngeal cancers. 

Specifically, HPV16 is recognized as the primary culprit behind oropharyngeal cancers, affecting areas such as the tonsils, tonsillar crypt, base of the tongue, and occasionally the front of the mouth or oral cavity. Notably, there’s a discrepancy in the prevalence of oropharyngeal cancers between males and females, with more males being affected. This highlights the significance of understanding HPV’s impact on different genders and its role in cancer development. 

The Link Between HPV and Mouth Cancer

Oropharyngeal cancers, which include cancers of the throat, tonsils, and base of the tongue, have been increasingly associated with HPV infection, particularly with HPV type 16. Studies have shown that HPV-related oropharyngeal cancers tend to affect younger individuals who do not have traditional risk factors for oral cancers, such as tobacco or alcohol use. This has led to a shift in the demographics of oral cancer patients, with more cases being attributed to HPV infection. 

The CDC approximates that HPV is responsible for about 70% of oropharyngeal cancers in the United States. However, it remains unclear whether HPV alone can directly lead to oropharyngeal cancer, as the process may take several years to progress. Factors like smoking or tobacco use may also play a role, potentially interacting with HPV to increase the risk of cancer development. 

Risk Factors for HPV-Related Mouth Cancer

The primary risk factor for developing HPV-related mouth cancer is exposure to the virus, usually through sexual activity. Other risk factors may include: 

• Age and Gender: HPV-related oropharyngeal cancers are more common in younger individuals and men. 
• Sexual Behavior: Engaging in unprotected oral sex or having multiple sexual partners increases the risk of HPV transmission. 
• Immune System Health: A weakened immune system due to conditions like HIV/AIDS or immunosuppressive medications can increase susceptibility to HPV-related cancers. 
• Genetic Factors: Certain genetic factors may play a role in how the body responds to HPV infection and the development of related cancers. 

Can the HPV Vaccine Protect Against Oropharyngeal Cancers?

The HPV vaccine was initially designed to prevent cancers related to the reproductive system, including cervical cancer. However, since the vaccine targets the types of HPV responsible for oropharyngeal cancers as well, it’s believed that it can also offer protection against these cancers. 

The CDC recommends HPV vaccination for individuals aged 11 to 12 years and also for everyone up to 26 years of age if they haven’t been vaccinated earlier. While vaccination is generally not recommended for those over 26 years old, some adults aged 27 to 45 who haven’t been vaccinated may choose to do so after discussing their risk factors with their healthcare provider. It’s important to note that the effectiveness of HPV vaccination decreases with age due to increased exposure to HPV over time. 

Symptoms of HPV moth cancer

• Persistent soreness or irritation  
• Red or white patches, tenderness, or numbness in the mouth or lips 
• Lumps, thickened tissues, rough spots, or areas that appear crusty or eroded 
• Difficulty with chewing, swallowing, speaking, or moving the jaw or tongue 
• Changes in the way teeth fit together when closing the mouth 

These symptoms may vary in severity and duration, and they can often be mistaken for common throat or respiratory issues. It’s essential to pay attention to any persistent or worsening symptoms like HPV Spots at the Back of Tongue.  

Diagnosis

Diagnosing HPV mouth cancer typically involves a comprehensive approach starting with a thorough physical examination. This examination includes a visual inspection of the mouth and throat to look for any abnormalities or suspicious lesions. Imaging tests like CT scans, MRI scans, or PET scans may also be used to assess the size and extent of the cancer, aiding in treatment planning. 

A definitive diagnosis usually requires a biopsy, where a small tissue sample is taken from the affected area and examined under a microscope by a pathologist. This biopsy helps determine the presence of cancerous cells and provides information about the type and stage of the cancer. Additionally, testing for HPV DNA or RNA in the tissue sample can further confirm the role of HPV in the development of cancer and guide treatment decisions. 

Treatment for HPV Mouth Cancer

Treatment options for HPV mouth cancer are diverse, encompassing surgical interventions like options to get rid of HPV bumps, radiation therapy, chemotherapy, and immunotherapy. Surgical procedures involve the removal of the tumor and adjacent tissues to eliminate cancerous cells and prevent further spread.  

Radiation therapy utilizes high-energy beams to target and destroy cancer cells, either alone or in combination with surgery. Chemotherapy employs drugs to kill cancer cells or impede their growth, often used alongside surgery and/or radiation. Immunotherapy, a cutting-edge approach, harnesses the body’s immune system to specifically target and eliminate cancer cells.  

These treatments are customized based on individual factors such as cancer stage, overall health, and treatment objectives, aiming to achieve optimal outcomes for patients with HPV-related mouth cancer. 

Prevention is the Key!

Preventing HPV mouth cancer primarily involves reducing exposure to the virus through safe sexual practices, including using condoms or dental dams during oral sex and getting vaccinated against HPV. The HPV vaccine is recommended for adolescents and young adults, as it can protect against several high-risk HPV types, including HPV 16 and 18. 

Regular dental check-ups and oral cancer screenings are also important, especially for individuals at higher risk due to HPV infection or other risk factors. Early detection through screenings can lead to prompt treatment and better outcomes for patients with oral cancers, including those related to HPV. 

Conclusion

In conclusion, while HPV is often linked to cervical cancer, it can also contribute to mouth cancer, like oropharyngeal cancers. This connection is crucial for healthcare professionals to consider in screenings and treatments. Encouraging safe sex practices, HPV vaccination, and regular check-ups can help lower the risk of HPV mouth cancers and improve overall oral health. 

Also Read: The Impact of Tobacco Packaging